# Cannabis for the Prophylactic Treatment of Migraine

> **NCT03972124** · PHASE2 · RECRUITING · sponsor: **University of Calgary** · enrollment: 72 (estimated)

## Conditions studied

- Chronic Migraine

## Interventions

- **DRUG:** CBD 100 mg OD
- **DRUG:** CBD 200 mg OD
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03972124
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03972124

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03972124, "Cannabis for the Prophylactic Treatment of Migraine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03972124. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*